InsiderClue
← All stocks

Nurix Therapeutics, Inc.

NRIX Scheduled selling only
CIK 0001549595 #1793 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$4.53M
$1.35M on a plan · $3.18M straight out of an exercise
Sold at will
$0.00
0 of 40 sales
Net
−$4.53M
$0.00 against sales at will

By person

4 insiders · 42 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ring Christine
Chief Legal Officer
—
$3.26M (20) scheduled
−$3.26M
9,110
0.0088%
$242.67K
−63.0%
van Houte Hans
Chief Financial Officer
—
$635.33K (10) scheduled
−$635.33K
40,166
0.0387%
$1.07M
+29.6%
Hansen Gwenn
Chief Scientific Officer
—
$630.90K (10) scheduled
−$630.90K
117,227
0.1130%
$3.12M
+159.6%
GREGORY JULIA P
Director
—
—
—
10,750
0.0104%
$286.35K
—

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
van Houte Hans
4 Aug 2026
Chief Financial Officer
Sold on a plan
2,967
$24.65
$73.13K
van Houte Hans
4 Aug 2026
Chief Financial Officer
Sold on a plan
1,794
$23.89
$42.86K
Hansen Gwenn
4 Aug 2026
Chief Scientific Officer
Sold on a plan
2,611
$24.64
$64.34K
Hansen Gwenn
4 Aug 2026
Chief Scientific Officer
Sold on a plan
1,500
$23.87
$35.80K
Hansen Gwenn
25 Jun 2026
Chief Scientific Officer
Sold on a plan
5,394
$20.00
$107.88K
van Houte Hans
5 May 2026
Chief Financial Officer
Sold on a plan
582
$17.18
$10.00K
van Houte Hans
5 May 2026
Chief Financial Officer
Sold on a plan
13,473
$16.58
$223.32K
Ring Christine
4 May 2026
Chief Legal Officer
Sold on a plan
8,148
$16.96
$138.21K
Ring Christine
1 May 2026
Chief Legal Officer
Sold on a plan
5,394
$16.76
$90.41K
Ring Christine
2 Apr 2026
Chief Legal Officer
Sold on a plan
8,148
$15.24
$124.15K
Ring Christine
2 Mar 2026
Chief Legal Officer
Sold on a plan
8,148
$15.44
$125.79K
Ring Christine
9 Feb 2026
Chief Legal Officer
Sold on a plan
14,261
$16.66
$237.62K
van Houte Hans
3 Nov 2025
Chief Financial Officer
Sold on a plan
6,284
$12.56
$78.93K
Show all 42 transactions →

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 27
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 272,001
History held since 29 Jul 2020